Raman Singh

Employment

• Shoolini University Associate Professor
  2016 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (32)

• Experimental and Computational Investigation of New Geranyl-Based Ionic Liquids on Mild Steel as Corrosion Inhibitors in Chloride Media
  Industrial & Engineering Chemistry Research 2026 DOI: 10.1021/acs.iecr.5c04209
  +Save
• Interaction of Nanoparticles with Multidrug-Resistant Bacteria
  ACS Omega 2025 DOI: 10.1021/acsomega.5c07739
  +Save
• Antibacterial and antibiofilm activity of nanoparticles in Klebsiella quasipneumoniae
  RSC Advances 2025 DOI: 10.1039/D5RA04828A
  +Save
• HRMAS-NMR and simulation study of the self-assembly of surfactants on carbon nanotubes
  Physical Chemistry Chemical Physics 2023 DOI: 10.1039/D2CP03762A
  +Save
• Stabilization of Carbon Nanotubes and Graphene by Tween-80: Mechanistic Insights from Spectroscopic and Simulation Studies
  Langmuir 2022 DOI: 10.1021/acs.langmuir.2c01190
  +Save
• Nanoparticles Incorporating a Fluorescence Turn-on Reporter for Real-Time Drug Release Monitoring, a Chemoenhancer and a Stealth Agent: Poseidon’s Trident against Cancer?
  Molecular Pharmaceutics 2021 DOI: 10.1021/acs.molpharmaceut.0c00730
  +Save
• Carbon Nanotubes Modulate Activity of Cytotoxic Compounds via a Trojan Horse Mechanism
  Chemical Research in Toxicology 2020 DOI: 10.1021/acs.chemrestox.9b00370
  +Save
• Sonochemical Decoration of Graphene Oxide with Magnetic Fe3O4@CuO Nanocomposite for Efficient Click Synthesis of Coumarin-Sugar Based Bioconjugates and Their Cytotoxic Activity
  Catalysis Letters 2019 DOI: 10.1007/s10562-019-02982-6
  +Save
• Nanotoxicology: Contemporary issues and future directions
  Advances in Delivery Science and Technology 2018 DOI: 10.1007/978-3-319-11355-5_23
  +Save
• Erratum: Intranuclear Drug Delivery and Effective in Vivo Cancer Therapy via Estradiol-PEG-Appended Multiwalled Carbon Nanotubes (Mol. Pharmaceutics (2013) 10:9 (3404-3416) DOI: 10.1021/mp4002409)
  Molecular Pharmaceutics 2016 DOI: 10.1021/acs.molpharmaceut.5b00964
  +Save